Antidepressants Global Market Report 2024

Global Antidepressants Market Report 2024

Antidepressants Global Market Report 2024 – By Product (Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)), By Drug Class (Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants), By Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder) – Market Size, Trends, And Global Forecast 2024-2033

Name: Antidepressants Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Antidepressants Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Antidepressants Market Definition

Antidepressants refer to a medication that aids in the treatment of depressive symptoms. Additionally, they can aid in the treatment of SAD, other anxiety disorders, and social anxiety disorder. Unpleasant side effects are possible with antidepressants. Initially, signs and symptoms including nausea, weight gain, or sleep issues can be prevalent.

The main product types of antidepressants are selective serotonin reuptake inhibitor (SSRI), serotonin-norepinephrine reuptake inhibitor (SNRI), tricyclic antidepressant (TCA), and monoamine oxidase inhibitor (MAOI). SSRIs (selective serotonin reuptake inhibitors) are a type of medication that is commonly used to treat depression and a few other mental illnesses. The various drug class includes monoamine oxidase inhibitors, serotonin antagonist and reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors, and tricyclic antidepressants that are used for the treatment of the major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, and panic disorder.

Antidepressants Market Segmentation

The antidepressants market covered in this report is segmented –

1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)

2) By Drug Class: Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants

3) By Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder

Global Antidepressants Market Size 2023 to 2028: Graph

Antidepressants Market Size 2024 And Growth Rate

The antidepressants market size has grown steadily in recent years. It will grow from $16.6 billion in 2023 to $17.32 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to increasing prevalence of mental health disorders, growing awareness and reduced stigma, advancements in diagnostic practices, expansion of treatment options, government initiatives and mental health policies.

Antidepressants Market Growth Forecast

The antidepressants market size is expected to see steady growth in the next few years. It will grow to $19.88 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%. The growth in the forecast period can be attributed to rising mental health awareness and advocacy, global impact of stress and lifestyle changes, integration of mental health services, research and development in psychiatry, telemedicine and remote mental health services. Major trends in the forecast period include regulatory changes, market competition, generic market growth, focus on side effect profiles, emerging markets.

Book your 30 minutes free consultation with our research experts

Antidepressants Market Driver: Surge In Mental Health Disorders Fuels Antidepressant Drug Industry Growth

Globally, rising cases of mental health disorders are the key factor in the growth of the antidepressant drug industry, as many customers rely on these medications to counter depression, anxiety disorder, and other mental diseases. Antidepressant medications are used in conditions such as depression, OCD, childhood enuresis, major depressive disorder, severe anxiety disorder, bipolar disorder, post-traumatic stress disorder (PTSD), and social anxiety disorder. Globally, the percentage of people with depression varies from 2% to 6%, and the elderly are at greater risk of depression compared to other age groups. According to WHO, in 2023, about 280 million people globally suffered from depression. Therefore, rising cases of mental health disorders are expected to drive the growth of the antidepressant market.

Antidepressants Market Driver: Rising Cases Of Mental Illness

The increasing mental illness is expected to propel the demand for the antidepressants market going forward. A mental illness is a disorder that impacts the way a person thinks, feels, behaves, or believes. These illnesses occur due to distress or difficulties functioning in social, job, or family activities. Antidepressants are a type of medication used to treat various mental health conditions, including depression, anxiety, and mood disorders. It works by increasing the levels of certain chemicals in the brain that are responsible for regulating mood and emotions. For instance, in June 2022, according to the World health organization, a US-based government agency report on world mental health, 970 million individuals worldwide had a mental disorder in 2019. Additionally, in June 2022, the National Alliance on Mental Illness, a US-based nonprofit organization, 21% of US adults faced mental illness in 2020, accounting for 52.9 million people representing 1 in 5 adults. Therefore, increasing mental illness will drive the antidepressants market.

Global Antidepressants Market Major Players

Major companies operating in the antidepressants market report are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol Myers Squibb Company, Fresenius Kabi AG, Abbott Laboratories, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd., Eli Lilly and Company, Boehringer Ingelheim GmbH, H. Lundbeck AS, Teva Pharmaceutical Industries Ltd., Akeda Pharmaceutical Co., Otsuka Pharmaceutical Co., Mylan N.V, Sun Pharmaceuticals Pvt. Ltd., Servier Laboratories, Sumitomo Dainippon Pharma Co., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Allergan plc, Alkermes plc, Egis Pharmaceuticals plc, Forest Laboratories Inc.

Global Antidepressants Market Restraint: Adverse Effects Of Antidepressants A Hurdle In The Market Growth

The side effects of antidepressant drugs are a key factor hampering the growth of the antidepressant market. For instance, the antidepressants Lexapro (escitalopram) and Celexa (citalopram), both are used to treat depression and Lexapro also helps for treating anxiety. Lexapro and Celexa can cause side effects common to others which include nausea, sleeplessness, sweating, dry mouth, and drowsiness. Celexa and Lexapro are both at risk for even more serious side effects including excessive bleeding, seizures, and vision issues. Therefore, the side effects of antidepressant drugs are expected to limit the growth of the antidepressant market.

Global Antidepressants Market Trend: Ketamine Treatment Reshaping The Antidepressant Market

The treatment of resistant depression is a key trend in the antidepressant market. Ketamine is the new treatment that is used for anesthesia during surgery, stimulates the development of glutamate, and prompts the brain to form new neural connections. It makes the brain more adaptable and capable of developing new pathways and helps people to create more optimistic thoughts and behaviors. For instance, Food and Drug Administration (FDA) approved a new ketamine depression drug esketamine which is one-half of the ketamine compound. The drug must be administered as a nasal spray and patients must be taking another antidepressant at the same time. Also, the drugs can be prescribed to only those patients who have (unsuccessfully) tried two antidepressants before.

Global Antidepressants Market Trend: Novel Treatment Introduction In The Antidepressant Market

Major companies operating in the antidepressant market are increasing their focus on introducing new drugs such as the ZURZUVAE™ (zuranolone) for treatment of postpartum depression (PPD) to maximize revenue in the market. Postpartum depression (PPD) is a type of depression that can occur after giving birth. It is a serious mental health condition that can affect both new mothers and fathers. For instance, in August 2023, Biogen Inc a US-based biotechnology company and Sage Therapeutics, Inc. US-based a biopharmaceutical company launched ZURZUVAE™ (zuranolone), a 50 mg oral treatment for postpartum depression (PPD) in women. This marks a significant advancement, addressing the underdiagnosed and undertreated condition of PPD. ZURZUVAE™ (zuranolone) is an oral treatment primarily used for postpartum depression (PPD) and is the first and only FDA-approved medication designed specifically for this condition.

Antidepressants Market Merger And Acquisition:

Strategic Acquisition Shineco. Expands Portfolio With Beijing Wonner Biotech Partnership

In October 2021, ShineCo., Inc., a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, and other biotech products, announced that it has entered into a framework agreement to acquire a majority stake in Beijing Wonner Biotech Co., Ltd., for a deal amount of $30 million. Through this acquisition, Shineco aims to jointly develop SNG, a rapid-acting antidepressant natural innovative medicine. Beijing Winner is a biotechnology company based in China that specializes in the research and development of natural medicines and related products.

Regional Insights For The Global Antidepressants Market

North America was the largest region in the antidepressants market in 2023. Middle East is expected to be the largest growing region in the global antidepressants market during the forecast period. The regions covered in the antidepressants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antidepressants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The antidepressants market consists of sales of duloxetine, desvenlafaxine, vilazodone, citalopram, and sertraline. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The antidepressants market research report is one of a series of new reports from The Business Research Company that provides antidepressants market statistics, including antidepressants industry global market size, regional shares, competitors with an antidepressants market share, detailed antidepressants market segments, market trends, and opportunities, and any further data you may need to thrive in the antidepressants industry. This antidepressants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Antidepressants Market Report Forecast And Analysis

Report Attribute	Details
Market Size Value In 2024	$17.32 billion
Revenue Forecast In 2033	$19.88 billion
Growth Rate	CAGR of 3.5% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI) 2) By Drug Class: Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants 3) By Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Novartis AG; Sanofi S.A.; Bristol Myers Squibb Company; Fresenius Kabi AG; Abbott Laboratories; AstraZeneca plc; GlaxoSmithKline plc; Takeda Pharmaceutical Co. Ltd.; Eli Lilly and Company; Boehringer Ingelheim GmbH; H. Lundbeck AS; Teva Pharmaceutical Industries Ltd.; Akeda Pharmaceutical Co.; Otsuka Pharmaceutical Co.; Mylan N.V; Sun Pharmaceuticals Pvt. Ltd.; Servier Laboratories; Sumitomo Dainippon Pharma Co.; Aurobindo Pharma Limited; Dr. Reddy's Laboratories Ltd.; Hikma Pharmaceuticals plc; Allergan plc; Alkermes plc; Egis Pharmaceuticals plc; Forest Laboratories Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Antidepressants Market Characteristics

3. Antidepressants Market Trends And Strategies

4. Antidepressants Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Antidepressants Market Size and Growth

5.1. Global Antidepressants Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Antidepressants Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Antidepressants Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Antidepressants Market Segmentation

6.1. Global Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Selective Serotonin Reuptake Inhibitor (SSRI)

Serotonin-norepinephrine Reuptake Inhibitor (SNRI)

Tricyclic Antidepressant (TCA)

Monoamine Oxidase Inhibitor (MAOI)

6.2. Global Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Monoamine Oxidase Inhibitors

Serotonin Antagonist And Reuptake Inhibitors

Serotonin-Norepinephrine Reuptake Inhibitors

Selective Serotonin Reuptake Inhibitors

Tricyclic Antidepressants

6.3. Global Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Major Depressive Disorder

Obsessive-Compulsive Disorder

Generalized Anxiety Disorder

Panic Disorder

7. Antidepressants Market Regional And Country Analysis

7.1. Global Antidepressants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Antidepressants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Antidepressants Market

8.1. Asia-Pacific Antidepressants Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Antidepressants Market

9.1. China Antidepressants Market Overview

9.2. China Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Antidepressants Market

10.1. India Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Antidepressants Market

11.1. Japan Antidepressants Market Overview

11.2. Japan Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Antidepressants Market

12.1. Australia Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Antidepressants Market

13.1. Indonesia Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Antidepressants Market

14.1. South Korea Antidepressants Market Overview

14.2. South Korea Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Antidepressants Market

15.1. Western Europe Antidepressants Market Overview

15.2. Western Europe Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Antidepressants Market

16.1. UK Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Antidepressants Market

17.1. Germany Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Antidepressants Market

18.1. France Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Antidepressants Market

19.1. Italy Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Antidepressants Market

20.1. Spain Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Antidepressants Market

21.1. Eastern Europe Antidepressants Market Overview

21.2. Eastern Europe Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Antidepressants Market

22.1. Russia Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Antidepressants Market

23.1. North America Antidepressants Market Overview

23.2. North America Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Antidepressants Market

24.1. USA Antidepressants Market Overview

24.2. USA Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Antidepressants Market

25.1. Canada Antidepressants Market Overview

25.2. Canada Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Antidepressants Market

26.1. South America Antidepressants Market Overview

26.2. South America Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Antidepressants Market

27.1. Brazil Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Antidepressants Market

28.1. Middle East Antidepressants Market Overview

28.2. Middle East Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Antidepressants Market

29.1. Africa Antidepressants Market Overview

29.2. Africa Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Antidepressants Market Competitive Landscape And Company Profiles

30.1. Antidepressants Market Competitive Landscape

30.2. Antidepressants Market Company Profiles

30.2.1. Pfizer Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Johnson & Johnson Services Inc.

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. F. Hoffmann-La Roche Ltd.

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Merck & Co. Inc.

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. AbbVie Inc.

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Antidepressants Market Other Major And Innovative Companies

31.1. Novartis AG

31.2. Sanofi S.A.

31.3. Bristol Myers Squibb Company

31.4. Fresenius Kabi AG

31.5. Abbott Laboratories

31.6. AstraZeneca plc

31.7. GlaxoSmithKline plc

31.8. Takeda Pharmaceutical Co. Ltd.

31.9. Eli Lilly and Company

31.10. Boehringer Ingelheim GmbH

31.11. H. Lundbeck AS

31.12. Teva Pharmaceutical Industries Ltd.

31.13. Akeda Pharmaceutical Co.

31.14. Otsuka Pharmaceutical Co.

31.15. Mylan N.V

32. Global Antidepressants Market Competitive Benchmarking

33. Global Antidepressants Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Antidepressants Market

35. Antidepressants Market Future Outlook and Potential Analysis

35.1 Antidepressants Market In 2028 - Countries Offering Most New Opportunities

35.2 Antidepressants Market In 2028 - Segments Offering Most New Opportunities

35.3 Antidepressants Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Antidepressants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Antidepressants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Asia-Pacific, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: China, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: India, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: Japan, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Australia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Indonesia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: South Korea, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: Western Europe, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: UK, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: Germany, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: France, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: Italy, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Spain, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Eastern Europe, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Russia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: North America, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: USA, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: Canada, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: South America, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: Brazil, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Middle East, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Africa, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Pfizer Inc. Financial Performance

Table 75: Johnson & Johnson Services Inc. Financial Performance

Table 76: F. Hoffmann-La Roche Ltd. Financial Performance

Table 77: Merck & Co. Inc. Financial Performance

Table 78: AbbVie Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Antidepressants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Antidepressants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Asia-Pacific, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: China, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: India, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: Japan, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Australia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Indonesia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: South Korea, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: Western Europe, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: UK, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: Germany, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: France, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: Italy, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Spain, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Eastern Europe, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Russia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: North America, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: USA, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: Canada, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: South America, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: Brazil, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Middle East, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Africa, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Pfizer Inc. Financial Performance

Figure 75: Johnson & Johnson Services Inc. Financial Performance

Figure 76: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 77: Merck & Co. Inc. Financial Performance

Figure 78: AbbVie Inc. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the stem cell therapy market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the regenerative medicine for cartilage market research report 2022 with industry size, share, segments and market growth

Inflammatory Bowel Disease Treatment Global Market Report 2024 – By Drug Class (Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes), By Type (Crohn's Disease, Ulcerative Colitis), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Dermatitis Global Market Report 2024 – By Drug Class (Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors ), By Distribution Channel (Hospital, Retail Pharmacies, Drug Stores, Online Or Mail Pharmacies), By Application (Cancer, Blood Disorders, Chronic Diseases, Infectious Diseases) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Bipolar Disorder Therapeutics Global Market Report 2024 – By Drug Class (Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs), By Mechanism (Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Beta-Blockers, Other Mechanisms), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Nootropics Global Market Report 2024 – By Drug Type (Prescription Nootropics, OTC Nootropics), By Form (Capsules or Tablets, Powder, Drinks, Other Forms), By Distribution Channel (Offline, Online), By Application (Memory Enhancement, Mood and Depression, Attention and Focus, Longevity and Anti-aging, Sleep and Recovery, Anxiety ) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Drugs for Immunotherapy Global Market Report 2024 – By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types), By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Psychiatrists Global Market Report 2024 – By Mental Disorder Type (Alcohol Abuse Mental And Behavioral Disorders, Psychoactive Substance Use Mental And Behavioral Disorders, Schizophrenia, Schizotypal And Delusional Disorders, Mood (Anxiety And Depression) Disorders, and Other Mental And Behavioral Disorders), By Patient Type (Inpatient, and Outpatient), By Psychology Type (Social, Abnormal, Biological, Other Psychology Types) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Metabolic Disorders Drugs Global Market Report 2022 – By Type (Anti Diabetics drugs, Anti-Thyroid Drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Musculoskeletal Disorders Drugs Global Market Report 2022 – By Type (Drugs For Rheumatoid Arthritis, Muscle Relaxants, Other Musculoskeletal Disorders Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Frequently Asked Questions

What is the definition of the antidepressants market?

How will the antidepressants market drivers and restraints affect the antidepressants market dynamics? What forces will shape the antidepressants industry going forward?

The antidepressants market major growth driver - surge in mental health disorders fuels antidepressant drug industry growth. For further insights on the antidepressants market, request a sample here

What is the forecast market size or the forecast market value of the antidepressants market ?

The antidepressants market size has grown steadily in recent years. It will grow from $16.6 billion in 2023 to $17.32 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to increasing prevalence of mental health disorders, growing awareness and reduced stigma, advancements in diagnostic practices, expansion of treatment options, government initiatives and mental health policies. The antidepressants market size is expected to see steady growth in the next few years. It will grow to $19.88 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%. The growth in the forecast period can be attributed to rising mental health awareness and advocacy, global impact of stress and lifestyle changes, integration of mental health services, research and development in psychiatry, telemedicine and remote mental health services. Major trends in the forecast period include regulatory changes, market competition, generic market growth, focus on side effect profiles, emerging markets. For further insights on the antidepressants market, request a sample here

How is the antidepressants market segmented?

The antidepressants market is segmented
1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)
2) By Drug Class: Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants
3) By Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic DisorderFor further insights on the antidepressants market, request a sample here

Which region has the largest share of the antidepressants market? What are the other regions covered in the report?

North America was the largest region in the antidepressants market in 2023. Middle East is expected to be the largest growing region in the global antidepressants market during the forecast period. The regions covered in the antidepressants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the antidepressants market, request a sample here.

Who are the major players in the antidepressants market?

What are the key trends in the antidepressants market?

Major trend in the antidepressants market - ketamine treatment reshaping the antidepressant market. For further insights on the antidepressants market, request a sample here.

What are the major opportunities in the antidepressants market? What are the strategies for the antidepressants market?

For detailed insights on the major opportunities and strategies in the antidepressants market, request a sample here.

How does the antidepressants market relate to the overall economy and other similar markets?

For detailed insights on antidepressants market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the antidepressants industry?

For detailed insights on the mergers and acquisitions in the antidepressants industry, request a sample here.

What are the key dynamics influencing the antidepressants market growth? SWOT analysis of the antidepressants market.

For detailed insights on the key dynamics influencing the antidepressants market growth and SWOT analysis of the antidepressants industry, request a sample here.